| Trial ID: | L6179 |
| Source ID: | NCT00780715
|
| Associated Drug: |
Gliclazide Mr
|
| Title: |
Response To Oral Agents in Diabetes (ROAD)- Pilot Study
|
| Acronym: |
ROAD
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT00780715/results
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Gliclazide MR|DRUG: Sitagliptin|DRUG: Pioglitazone|DRUG: Metformin
|
| Outcome Measures: |
Primary: HbA1c Change, Units are absolute difference in %HbA1c (HbA1c being the percentage of glycated Haemoglobin, reflecting glucose exposure over the last 3 months), 6 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Dundee
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
29
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2008-12
|
| Completion Date: |
2009-10
|
| Results First Posted: |
2017-10-26
|
| Last Update Posted: |
2017-10-26
|
| Locations: |
Ninewells Hospital & Medical School, Dundee, DD1 9SY, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT00780715
|
